The combined enterprise value of Injeplast and CareFirst Specialty Pharmacy is roughly €30m. Credit: Matveev Aleksandr via Shutterstock.

Fagron, a leader in pharmaceutical compounding, has expanded its global footprint by acquiring Injeplast, a plastic packaging producer based in São Paulo, Brazil.

The strategic move aligns with Fagron’s Essentials strategy, aimed at broadening its product offerings and customer base in the South American market.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Injeplast, known for its good manufacturing practice-certified, vertically integrated production, contributes low double-digit annual revenue through its efficient packaging solutions.

This move is part of a larger expansion as Fagron has also announced the acquisition of CareFirst Specialty Pharmacy in North America.

CareFirst, a 503A pharmaceutical compounder located in New Jersey, US, specialises in the health and wellness sector.

The combined enterprise value of Injeplast and CareFirst Specialty Pharmacy is approximately €30m ($31m).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

These deals are fully financed through Fagron’s resources and are pending customary clearances.

Fagron CEO Rafael Padilla said: “We are incredibly pleased to announce these two acquisitions, which reflect our disciplined and strategic growth approach.

“The acquisition of CareFirst allows us to meet the increasing demand in the prevention and lifestyle segments, reinforcing our leadership in North America.

“Similarly, the addition of Injeplast will strengthen our market positioning in Latin America by broadening our product portfolio and expanding our customer base. Both businesses align with Fagron’s Group margin, and we expect to integrate them over the next 18 to 24 months.”